1. Presented by the UCLA Undergraduate Investment Society

2. Balance Sheet

3. Income Statement

4. Statement of Cashflow

5. Statement of Owners/Shareholders Equity

6. Recall… We use Financial Ratios to Analyze the Statements of Companies

7. Let’s Get Going We are going to look at 6 Companies 3 from the Retail Industry 3 from the Pharmaceutical Industry

8. Retail Industry Maidenforms Brands Inc. (MFB) True Religion Apparel Inc. (TRLG) Jones Group Inc. (JNY)

9. Maidenforms Band Inc. MFB Maidenform Brands, Inc. is a global intimate apparel company that designs, sources and markets a range of intimate apparel products, including bras, panties and shapewear. As of December 31, 2011, the Company operated 74 outlet stores. In addition, the Company sells products, such as sleepwear, bra accessories and girls bras under the Maidenform label, which it purchases from its licensees and other third-party vendors. It operates in two segments: wholesale and retail.

10. Balance Sheet

11. Income Statement

12. Cash Flows

13. Ratios Liquidity/Financial Health 2008-122009-122010-122011-12 Latest Qtr Current Ratio 3.313.193.874.124.29 Quick Ratio 1.581.811.961.92.19 Financial Leverage 2.492.151.851.771.72 Debt/Equity 0.730.520.360.30.28

14. More Ratios Profitability2008-122009-122010-122011-12 Return on Assets % 8.5611.2612.718.87 Financial Leverage (Average) 2.492.151.851.77 Return on Equity % 22.5525.8325.3316.04 Return on Invested Capital % 12.4416.0117.5912

15. True Religion Apparel Inc. (TRLG) True Religion Apparel, Inc. (True Religion) designs, markets, sells and distributes premium fashion apparel, centered on its core denim products using the brand name True Religion Brand Jeans. The Company operates in four segments: U.S. Consumer Direct, International, U.S. Wholesale and Core Services. The Company’s products are distributed through multiple wholesale and retail segments on six continents, including North America, Europe, Asia, Australia, Africa and South America.

16. Balance Sheet

17. Income Statement

18. Cash Flows

19. Ratios Liquidity/Financial Health 2008-122009-122010-122011-12 Latest Qtr Current Ratio 7.098.797.747.357.8 Quick Ratio 5.136.445.785.485.47 Financial Leverage 1.171.161.191.21.18 Debt/Equity —————

20. More Ratios Profitability2008-122009-122010-122011-12 Return on Assets % 31.7323.8916.5513.71 Financial Leverage (Average) 1.171.161.191.2 Return on Equity % 37.3727.8319.4716.39 Return on Invested Capital % 37.3727.8319.4716.39

21. Jones Group Inc. (JNY) The Jones Group Inc. (Jones) is a global designer, marketer and wholesaler of over 35 brands across five divisions: apparel, footwear, jeans wear, jewelry and handbags. Jones also markets directly to consumers through its branded specialty retail and outlet stores and through its e-commerce sites. Its operations consist of six segments: domestic wholesale sportswear, domestic wholesale jeanswear, domestic wholesale footwear and accessories, domestic retail, international wholesale and international retail. On June 2, 2011, the Company acquired 100% of the equity interests in KG Group Holdings Limited.

22. Balance Sheet

23. Income Statement

24. Cash Flows

25. Ratios Liquidity/Financial Health 2008-122009-122010-122011-12 Latest Qtr Current Ratio 2.133.292.941.991.96 Quick Ratio 1.161.961.471.011.02 Financial Leverage 2.051.852.052.492.52 Debt/Equity 0.450.480.470.780.8

26. More Ratios Profitability2008-122009-122010-122011-12 Return on Assets % -27.03-3.892.472.01 Financial Leverage (Average) 2.051.852.052.49 Return on Equity % -48.15-7.614.824.55 Return on Invested Capital % -32.27-4.833.262.8

27. Retail Industry Sequenom, Inc. (SQNM) Affymetrix, Inc. (AFFX) MAKO Surgical Corp. (MAKO)

28. Sequenom, Inc. (SQNM) Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research. The Company operates in two segments: Molecular Diagnostics (including Sequenom Center for Molecular Medicine, LLC, or Sequenom CMM) and Genetic Analysis

29. Balance Sheet

30. Income Statement

31. Cash Flows

32. Ratios Liquidity/Financia l Health 2002-122003-122004-122005-122006-12 Current Ratio3.953.363.191.523.2 Quick Ratio3.362.632.390.82.77 Financial Leverage1.411.461.542.081.57 Debt/Equity0.090.080.12——

33. More Ratios Profitability2002-122003-122004-122005-122006-12 Tax Rate %————— Net Margin %-666-121.25-154.24-136.64-61.68 Asset Turnover (Average) 0.120.230.270.470.89 Return on Assets % -81.82-28.49-42.38-64-54.66

34. Affymetrix, Inc. (AFFX) Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The Company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies, as well as academic research centers, government research laboratories, private foundation laboratories and clinical reference laboratories in North America and Europe. In June 2012, the Company acquired eBioscience Holding Company, Inc.

35. Balance Sheet

36. Income Statement

37. Cash Flows

38. Ratios Liquidity/ Financial Health 2008-122009-122010-122011-12Latest Qtr Current Ratio6.345.823.95.762.77 Quick Ratio5.424.82.814.651.15 Financial Leverage 2.352.121.571.591.92 Debt/Equity1.040.830.330.350.6

39. More Ratios Profitability2008-122009-122010-122011-12 Return on Assets % -33.34-3.56-1.87-6.27 Financial Leverage (Average) 2.352.121.571.59 Return on Equity % -68.27-7.95-3.46-9.91 Return on Invested Capital % -37.22-4.1-2.19-7.42

40. MAKO Surgical Corp. (MAKO) MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for orthopedic procedures called MAKOplasty. The Company offers MAKOplasty, a surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using its RIO Robotic Arm Interactive Orthopedic system (RIO).. During the year ended December 31, 2011, a total of 48 RIO systems were sold worldwide.

41. Balance Sheet

42. Income Statement

43. Cash Flows

44. Ratios Liquidity/ Financial Health 2008-122009-122010-122011-12Latest Qtr Current Ratio3.929.546.373.383.37 Quick Ratio3.338.255.62.591.98 Financial Leverage 1.31.091.131.271.29 Debt/Equity—————

45. More Ratios Profitability2008-122009-122010-122011-12 Return on Assets % -64.99-36.66-32.76-27.29 Financial Leverage (Average) 1.31.091.131.27 Return on Equity % -317.64-43.26-36.4-32.53 Return on Invested Capital % -317.64-43.26-36.4-32.53

46. Now its time to practice!